Enhanced Vancomycin Hemodialysis model now available in DoseMeRx!Learn more →

From Theory to Practice: Maximizing Aminoglycoside Efficacy with AUC-guided TDM 

Featured speaker

Tony Lai, Bpharm, GradDipClinPharm, MClinPharm, FSHP

Senior Pharmacist, Antimicrobial Stewardship

Hosted by

Sharmeen Roy, PharmD, BCPS

Chief Strategy & Science Officer, DoseMe

In this webinar, Tony Lai, Senior Pharmacist, Antimicrobial Stewardship/Infectious Diseases, at The Children’s Hospital at Westmead, Australia makes the case for AUC-guided therapeutic drug monitoring (TDM) of aminoglycosides. 

Learn about the key benefits of AUC-guided TDM for gentamicin, tobramycin, and amikacin and gain real-world insights on implementing precision dosing to improve outcomes.

What you’ll learn

  • Best practices for therapeutic drug monitoring of gentamicin, tobramycin and amikacin
  • Explore the peak/trough vs. AUC dosing „controversy“
  • Learn how AUC guided monitoring seamlessly incorporates the latest CLSI updates to advance antibiotic stewardship
  • Build an aminoglycoside TDM protocol and review the guidelines used by The Children’s Hospital at Westmead 
  • Tony’s top tips for making your own business case

Watch the recording

Meet the speaker

Tony Lai, Bpharm, GradDipClinPharm, MClinPharm, FSHP

Tony Lai is a clinician-researcher based at The Children’s Hospital at Westmead and a clinical lecturer at the University of Sydney. He is a specialist pharmacist in antimicrobial stewardship and infectious diseases with experience in an extensive range of Sydney hospitals spanning over 15 years in paediatrics and adults. His expert advisory editor roles include the Society of Hospital Pharmacy Australia (SHPA) Injectables Drugs Handbook, Australasian Neonatal Medicines Formulary (ANMF) and the upcoming Therapeutic Guidelines: Antibiotic. He is a member of the New South Wales (NSW) Health AMS Expert Advisory Committee, the NSW Health Tuberculosis (TB) Advisory Committee and NSW Health High Consequences Infectious Diseases (HCID) Committee. His research interest is dose optimisation of antimicrobials and is currently a PhD candidate investigating liposomal amphotericin B therapeutic drug monitoring in children.


Drug models

Simplify TDM with clinically validated drug models for aminoglycosides & a wide range of other drugs.

EHR integration

DoseMeRx’s secure, user-friendly platform works seamlessly with the widest range of hospital systems.

Demo anfordern

Sehen Sie, wie einfach DoseMeRx zu bedienen und in Ihren Arbeitsalltag zu integrieren ist.

Fordern Sie unten eine Demo an. Sie können uns auch anrufen unter +1 (832) 358-3308 oder eine E-Mail an hello@dosemehealth.com senden.

Why should you choose DoseMeRx?

trusted by clincians
1:1 customer support

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.